Skip to main content
SpringerLink
Log in
Book cover

Illustrated Handbook of Rheumatic and Musculo-Skeletal Diseases pp 343–367Cite as

Adverse Drug Reactions in Rheumatology

  • Chapter
  • First Online:

  • 2111 Accesses

Abstract

There is a high probability of developing adverse drug reactions (ADRs) in rheumatology. Corticosteroids (CS) as well as different classes of disease-modifying anti-rheumatic drugs (DMARDs) are the commonest suspected drugs for variable ADRs. Even if these drugs are widely known for their efficacy on rheumatic diseases, it is necessary to know what to expect and how to treat a possible ADR. At this chapter we present some common but also some more seldom ADRs.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References and Further Reading

  • Bonomo L, Ghoneim S, Levitt J. A case of granuloma Annulare associated with Secukinumab use. Case Rep Dermatol Med. 2017;2017:5918708.

    PubMed  PubMed Central  Google Scholar 

  • Costanzo L, Ayala F, Megna M, et al. The risk of herpes zoster in the anti-TNF-α era: a case report and review of the literature. J Dermatol Case Rep. 2013;7(1):1–4.

    Article  Google Scholar 

  • Devos SA, Van Den Bossche N, De Vos M, Naeyaert JM. Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy. Dermatology. 2003;206(4):388–90.

    Article  CAS  Google Scholar 

  • Exarchou SA, Voulgari PV, Markatseli TE, Zioga A, Drosos AA. Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors. Scand J Rheumatol. 2009;38(5):328–31.

    Article  CAS  Google Scholar 

  • Kaltsonoudis E, Zikou AK, Voulgari PV, Konitsiotis S, Argyropoulou MI, Drosos AA. Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study. Arthritis Res Ther. 2014;16(3):R125.

    Article  Google Scholar 

  • Markatseli TE, Kaltsonoudis ES, Voulgari PV, Zioga A, Drosos AA. Induction of psoriatic skin lesions in a patient with rheumatoid arthritis treated with rituximab. Clin Exp Rheumatol. 2009;27(6):996–8.

    CAS  PubMed  Google Scholar 

  • Marra F, Lo E, Kalashnikov V, et al. Risk of herpes zoster in individuals on biologics, disease-modifying antirheumatic drugs, and/or corticosteroids for autoimmune diseases: a systematic review and meta-analysis. Open Forum Infect Dis. 2016;3(4):ofw205.

    Article  Google Scholar 

  • Moustou AE, Matekovits A, Dessinioti C, Antoniou C, Sfkikakis PP, Stratigos AJ. Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review. J Am Acad Dermatol. 2009;61(3):486–504.

    Article  CAS  Google Scholar 

  • Nikas SN, Kittas G, Karamaounas N, Drosos AA. Meloxicam-induced erythema multiforme. Am J Med. 1999;107(5):532–4.

    Article  CAS  Google Scholar 

  • Nikas SN, Voulgari PV, Drosos AA. Urticaria and angiedema-like skin reactions in a patient treated with adalimumab. Clin Rheumatol. 2007;26(5):787–8.

    Article  CAS  Google Scholar 

  • Pelechas E, Drosos AA. Hydroxychloroquine-induced dark butterfly rash in a rheumatoid arthritis patient. Rheumatology (Oxford). 2017; https://doi.org/10.1093/rheumatology/kex388.

    Article  Google Scholar 

  • Ratnarathorn M, Raychaudhuri SP, Naguwa S. Disseminated granuloma annulare: a cutaneous adverse effect of anti-tnf agents. Indian J Dermatol. 2011;56(6):752–4.

    Article  Google Scholar 

  • Sand FL, Thomsen SF. Off-label use of TNF-alpha inhibitors in a dermatological university department: retrospective evaluation of 118 patients. Dermatol Ther. 2015;28(3):158–65.

    Article  Google Scholar 

  • Sfikakis PP, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A. Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction. Arthritis Rheum. 2005;52(8):2513–8.

    Article  CAS  Google Scholar 

  • Viguier M, Richette P, Bachelez H, Wendling D, Aubin F. Paradoxical cutaneous manifestations during anti-TNF-alpha therapy. Ann Dermatol Venereol. 2010;137(1):64–71. quiz 63, 78-9.

    Article  CAS  Google Scholar 

  • Voulgari PV, Drosos AA. Gingival hyperplasia associated with cyclosporin A. J Rheumatol. 2002;29(11):2466.

    PubMed  Google Scholar 

  • Voulgari PV, Markatseli TE, Exarchou SA, Zioga A, Drosos AA. Granuloma annulare induced by anti-tumour necrosis factor therapy. Ann Rheum Dis. 2008;67(4):567–70.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology Clinic - Department of Internal Medicine, University of Ioannina, Ioannina, Greece

    Eleftherios Pelechas, Evripidis Kaltsonoudis, Paraskevi V. Voulgari & Alexandros A. Drosos

Authors
  1. Eleftherios Pelechas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Evripidis Kaltsonoudis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paraskevi V. Voulgari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alexandros A. Drosos
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pelechas, E., Kaltsonoudis, E., Voulgari, P.V., Drosos, A.A. (2019). Adverse Drug Reactions in Rheumatology. In: Illustrated Handbook of Rheumatic and Musculo-Skeletal Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-03664-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-03664-5_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-03663-8

  • Online ISBN: 978-3-030-03664-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation